Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Long-term Debt / Equity

Albireo Pharma Inc Long-term Debt / Equity Chart (ALBO)

Albireo Pharma Inc annual/quarterly Long-term Debt / Equity from 2015 to 2020.
  • Albireo Pharma Inc Long-term Debt / Equity for the quarter ending June 06, 2020 was $15m a 71.52% increase of 11m year over year
  • Albireo Pharma Inc Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $15m a 71.52% increase of 11m year over year
  • Albireo Pharma Inc Annual Long-term Debt / Equity for 2019 was $4m a 1,417.32% increase of 64m from 2018
  • Albireo Pharma Inc Annual Long-term Debt / Equity for 2015 was $-59m a -383.92% increase of 227m from 2014
  • Albireo Pharma Inc Annual Long-term Debt / Equity for 2014 was $-286m
Other Ratios Metrics:
  • Albireo Pharma Inc Total Debt / Capital for the quarter ending September 09, 2017 was $2m a -268.92% decrease of -6m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
  • Albireo Pharma Inc Total Debt / Equity for the quarter ending September 09, 2017 was $2m a -291.29% decrease of -6m year over year
View Chart On Koyfin

Quarterly ALBO Long-term Debt / Equity Data

06/2020$15m
03/2020$4m
12/2019$4m
09/2019$4m
06/2019$0m
03/2019$0m
09/2016$-28m
06/2016$-49m
12/2015$-59m

Annual ALBO Long-term Debt / Equity Data

2019$4m
2015$-59m
2014$-286m